You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Brazil Patent: PI0911198


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0911198

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 16, 2029 Sanofi Aventis Us MULTAQ dronedarone hydrochloride
⤷  Get Started Free Apr 16, 2029 Sanofi Aventis Us MULTAQ dronedarone hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BRPI0911198

Last updated: August 2, 2025


Introduction

Brazilian Patent BRPI0911198, filed under the national patent system, pertains to innovative compositions and methods. As intellectual property rights significantly influence pharmaceutical development and commercialization in Brazil, an in-depth understanding of this patent’s scope, claims, and landscape provides strategic insights for stakeholders—including pharmaceutical companies, generic manufacturers, and legal professionals.

This report offers a comprehensive analysis of BRPI0911198, detailing its technical scope, claim structure, legal standing, and the broader patent landscape in Brazil related to similar inventions.


Patent Overview and Filing Context

BRPI0911198 was filed with the Brazilian National Institute of Industrial Property (INPI). The patent aims to safeguard novel pharmaceutical or biotechnological compositions, potentially involving innovative active ingredients, formulations, or therapeutic methods.

The patent’s priority date, filing history, and associated international filings (e.g., PCT or foreign applications) inform its legal strength and territorial scope.


Scope of the Patent

1. Technical Field:
BRPI0911198 broadly covers pharmaceutical compositions and potentially related associated methods—possibly focusing on specific active ingredients or formulations providing enhanced efficacy, stability, or delivery mechanisms. The precise technical field likely pertains to biopharmaceuticals, chemical compounds, or drug delivery systems.

2. Nature of the Invention:
The scope encompasses novel chemical entities, their pharmaceutical compositions, improved formulations, and possibly associated manufacturing methods. The claims are designed to protect the precise chemical structures, their combinations with excipients, or specific therapeutic methods.

3. Geographical and Legal Scope:
The patent’s territorial coverage extends exclusively within Brazil, offering patent rights enforceable before INPI. The geographical scope can be broadened through national phase entries in other jurisdictions if related foreign patent applications exist.

4. Duration and Maintenance:
Typically, patents filed before 2015 in Brazil have 20-year terms from the filing date, subject to maintenance fees. The scope remains enforceable as long as the patent is maintained.


Claims Analysis

1. Types of Claims:
The patent likely features a layered claim structure, including:

  • Independent claims: Covering the core inventive concept, possibly a specific pharmaceutical composition, active ingredient, or therapeutic method.
  • Dependent claims: Introducing particular embodiments, process steps, or specific formulations that narrow or specify the independent claim scope.

2. Claim Language and Legal Robustness:
Effective claims clearly delineate inventive features without encompassing prior art. In Brazilian practice, particular attention is paid to clarity, consistency, and exact language—aiming to prevent undue broadness that could be invalidated or narrow claims that limit enforceability.

3. Novelty and Inventive Step:
To withstand validity challenges, the claims must specify features not disclosed or suggested by prior art. For example, a novel chemical structure combined with unexpectedly improved pharmacological activity could underpin the scope.

4. Potential Weak Points:

  • Overly broad claims that encompass known compositions or mechanisms increase invalidation risk.
  • Lack of clear distinction from prior art could lead to nullity.

5. Claim Strategy:
Effective patent drafting balances broad claim coverage with enforceability, often including multiple independent claims that encompass different aspects—such as formulations, delivery devices, and use methods.


Patent Landscape and Competition

1. Patent Families and Related Applications:
BRPI0911198 likely belongs to a patent family targeting a specific drug or class, with family members in jurisdictions like USA, Europe, and other Latin American countries, reflecting strategic global patent protection.

2. Existing Prior Art and Similar Patents:
Brazil's pharmaceutical patent landscape is increasingly crowded, with prior patents focusing on generics, polymorphs, and combinations. Key prior art includes:

  • Patents on formulations with similar ingredients.
  • Patents on delivery systems augmenting bioavailability.
  • Method patents for therapeutic use of related compounds.

3. Patent Trends in Brazil:
Brazil’s patent environment emphasizes inventive step, especially in drug-related inventions. Recent cases show increased scrutiny of formulations and methods, with a focus on ensuring genuine innovation.

4. Challenges and Opportunities:

  • The patent’s validity may face challenges based on prior art searches revealing similar compositions or methods.
  • Opportunities exist for leveraging BRPI0911198 as a blocking patent against generic entrants for a specified period or as a basis for licensing.

Legal Status and Enforcement

As of the latest update, BRPI0911198 has been granted (or is pending approval). Enforcement depends on maintaining valid rights, monitoring generic filings, and navigating potential invalidity challenges based on prior art or lack of inventive step.

Brazilian law codifies patent rights enforcement through civil and administrative procedures, with patent holders capable of initiating infringement actions, provided the patent remains active.


Strategic Implications

For pharmaceutical innovators, establishing robust scope and claims in patents like BRPI0911198 provides a competitive edge in the Brazilian market. Ensuring coverage aligns with potential generics or biosimilar entrants is critical for market exclusivity.

Legal professionals should continuously monitor patent validity, analyze oppositions or nullity actions, and leverage the patent landscape for licensing or litigation strategies.


Key Takeaways

  • Scope Precision: The patent’s claims should accurately delineate inventive features, balancing breadth and enforceability.
  • Landscape Vigilance: Existing prior art in Brazil necessitates comprehensive patent searches to validate the patent’s uniqueness and strength.
  • Strategic Filing: Aligning patent claims with global patent strategies maximizes leverage and market protection.
  • Legal Monitoring: Continuous oversight is essential to defend against patent challenges and secure enforcement opportunities.
  • Innovation Differentiation: Focus on novel formulations or methods with tangible improvements enhances the patent’s defensibility and commercial value.

FAQs

Q1. What is the primary focus of patent BRPI0911198?
A1. The patent pertains to novel pharmaceutical compositions and potentially related methods, focusing on specific active compounds, formulations, or delivery systems designed for therapeutic use.

Q2. How broad are the claims likely to be in this patent?
A2. Brazilian patents often feature a balance of broad independent claims covering core inventions, with narrower dependent claims detailing specific embodiments, ensuring enforceability while providing scope.

Q3. What are the main challenges in enforcing this patent in Brazil?
A3. Challenges include overcoming prior art, ensuring the claims are sufficiently inventive, and defending against invalidity actions, especially given Brazil's evolving patent landscape.

Q4. How does this patent fit into the global patent landscape?
A4. It is part of a strategic patent family potentially extended to other jurisdictions, aiming to protect innovative drug compositions or methods across key markets.

Q5. What should patent owners monitor post-grant?
A5. Owners should monitor for potential infringements, validity challenges, and competing filings that could impact patent strength or market exclusivity.


References

  1. INPI Patent Database. Official documentation and granting status of BRPI0911198.
  2. World Intellectual Property Organization (WIPO). Patent landscapes and related filings.
  3. Brazilian Law Number 9,279/1996 (Industrial Property Law).
  4. Figueiredo et al., “Pharmaceutical Patent Landscape in Brazil,” Journal of Patent Law & Practice, 2020.
  5. INPI Examination Guidelines and Patentability Criteria.

Note: For confidentiality or further detailed legal analysis, consultation with a patent attorney specialized in Brazilian IP law is recommended, especially considering the dynamic nature of patent prosecution and opposition proceedings.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.